Wednesday, March 4, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Fighting for Justice for Dr. Bockoff and His Chronic Pain Patients

My name is Kristen Ogden and I advocate for chronic pain patients. My husband, Louis Ogden, is one of the chronic pain patients I’m talking about. Consider the fact that Louis has suffered from pain since he was a child. Some of you already know the background of our efforts to intervene in the case of DEA vs. Dr. David Bockoff.

If you don’t, we invite you to go first to https://www.daily-remedy.com/as-i-sat-in-court-watching-the-dea/ and to https://www. https://www.daily-remedy.com/a-patients-plea-for-justice/.

If you have pain, or you know someone who does, or fear some day you will have pain, as we all age, then you may want to consider what we’re doing in court. The why of our cause is straightforward. We are seeking justice for doctors to use their skills and justice for pain patients who desperately need relief from unremitting pain. In our fight with the DEA administrator and the relevant courts, we knew we had to retain counsel. When I first spoke to John P. Flannery, a former federal prosecutor, and special counsel on the Hill, and trial lawyer for decades, Mr. Flannery asked what outcome did we wish. Without hesitation, I said, individually and collectively we want the right to be let alone, to have access to pain medications for my husband, Louis, and for all of these patients in the same straits. That’s what we want. Mr. Flannery launched our effort with our full support with a Motion to Intervene in the case of DEA vs. David Bockoff, as “interested persons,” suffering because Dr. Bockoff was cut off summarily from continuing our pain prescriptions. We hoped to get the prescriptions we needed for our unremitting pain, and to exonerate Dr. Bockoff so he could get back to work caring for his patients. Prescriptions for controlled pain medications can only be possible if there’s a qualified pain specialist to write the scrips … preferably one who is knowledgeable, compassionate, and who “gets it” about chronic pain and the patients who suffer from it. We filed the Motion to Intervene, and, as expected, the DEA Administrative Law Judge (ALJ) denied our motion.

Now we need more funds to continue our fight!

#DEA #administrative #law #DOJ #Flannery #opioids #opioid #crisis

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply

Your email address will not be published. Required fields are marked *

Videos

2027 Medicare Advantage & Part D Advance Notice

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!